Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma Patients.
BRAF
PD-1
adjuvant treatment
checkpoint blocker
melanoma
targeted therapy
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
12 May 2021
12 May 2021
Historique:
received:
05
04
2021
revised:
04
05
2021
accepted:
06
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
Adjuvant treatment of melanoma patients with immune-checkpoint inhibition (ICI) and targeted therapy (TT) significantly improved recurrence-free survival. This study investigates the real-world situation of 904 patients from 13 German skin cancer centers with an indication for adjuvant treatment since the approval of adjuvant ICI and TT. From adjusted log-binomial regression models, we estimated relative risks for associations between various influence factors and treatment decisions (adjuvant therapy yes/no, TT vs. ICI in
Identifiants
pubmed: 34065995
pii: cancers13102319
doi: 10.3390/cancers13102319
pmc: PMC8151445
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : DFG, German Research Foundation
ID : RTG 2535
Références
Dtsch Arztebl Int. 2019 Feb 22;116(8):119-126
pubmed: 30940340
Melanoma Res. 2014 Oct;24(5):468-74
pubmed: 25054915
Melanoma Manag. 2019 Oct 04;6(4):MMT33
pubmed: 31871622
Lancet Oncol. 2020 Mar;21(3):358-372
pubmed: 32007138
J Am Geriatr Soc. 2017 May;65(5):1056-1060
pubmed: 28306158
Clin Cancer Res. 2016 Feb 15;22(4):886-94
pubmed: 26446948
Eur J Cancer. 2017 Apr;75:24-32
pubmed: 28214654
Ann Oncol. 2008 Mar;19(3):583-9
pubmed: 17974555
Eur J Cancer. 2017 Sep;82:171-183
pubmed: 28692949
J Clin Oncol. 2018 Sep 10;36(26):2680-2683
pubmed: 30004815
Nature. 2019 Mar;567(7748):305-307
pubmed: 30894741
Cancer. 2009 Sep 1;115(17):3848-57
pubmed: 19517470
JAMA Oncol. 2015 Jun;1(3):359-68
pubmed: 26146664
Lancet. 2018 Sep 15;392(10151):971-984
pubmed: 30238891
Ann Oncol. 2020 Nov;31(11):1449-1461
pubmed: 32763452
N Engl J Med. 2017 Nov 9;377(19):1824-1835
pubmed: 28891423
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
J Clin Oncol. 2020 Nov 20;38(33):3925-3936
pubmed: 32946353
J Invest Dermatol. 2011 Mar;131(3):719-26
pubmed: 21150923
Eur J Cancer. 2019 Dec;123:83-91
pubmed: 31677550
Eur J Cancer. 2019 Jul;116:148-157
pubmed: 31200321
J Clin Oncol. 2011 Apr 1;29(10):1239-46
pubmed: 21343559
Lancet Oncol. 2020 Nov;21(11):1465-1477
pubmed: 32961119
N Engl J Med. 2017 Nov 9;377(19):1813-1823
pubmed: 28891408
J Clin Rheumatol. 2020 Jan 22;:
pubmed: 31977647
J Natl Compr Canc Netw. 2019 Apr 1;17(4):367-402
pubmed: 30959471
Med Care. 2005 Nov;43(11):1130-9
pubmed: 16224307
N Engl J Med. 2018 May 10;378(19):1789-1801
pubmed: 29658430
Crit Rev Oncol Hematol. 2007 Mar;61(3):255-60
pubmed: 17098441
Cancer Causes Control. 2019 Apr;30(4):409-415
pubmed: 30868330
J Clin Oncol. 2020 Aug 1;38(22):2543-2551
pubmed: 32530760
Br J Cancer. 2014 Jul 15;111(2):292-9
pubmed: 24918823
Epidemiol Rev. 2013;35:75-83
pubmed: 23372025
Eur J Cancer. 2019 Sep;119:18-29
pubmed: 31401470
J Clin Oncol. 2002 Sep 1;20(17):3703-18
pubmed: 12202672
Eur J Dermatol. 2020 Aug 1;30(4):389-396
pubmed: 32815816
Gesundheitswesen. 2011 Dec;73(12):888-92
pubmed: 22193898
Cochrane Database Syst Rev. 2013 Jun 18;(6):CD008955
pubmed: 23775773
J Clin Oncol. 2008 May 20;26(15):2532-7
pubmed: 18487570
J Clin Oncol. 2010 Jun 20;28(18):3042-7
pubmed: 20479405
J Clin Oncol. 2018 Dec 10;36(35):3441-3449
pubmed: 30343620
CA Cancer J Clin. 2017 Nov;67(6):472-492
pubmed: 29028110
BMC Cancer. 2006 Feb 27;6:44
pubmed: 16504154
Adv Exp Med Biol. 2014;810:120-40
pubmed: 25207363
Support Care Cancer. 2017 Jan;25(1):75-83
pubmed: 27557832
Melanoma Res. 2020 Apr;30(2):185-192
pubmed: 31651715
Acta Derm Venereol. 2020 Mar 18;100(6):adv00083
pubmed: 32057087
Curr Oncol. 2019 Dec;26(6):e755-e765
pubmed: 31896946
Melanoma Manag. 2020 Mar 19;7(1):MMT39
pubmed: 32399177
JAMA Oncol. 2020 Apr 1;6(4):519-527
pubmed: 31895407
Lancet. 2015 Feb 7;385(9967):549-62
pubmed: 25468153
Am Soc Clin Oncol Educ Book. 2019 Jan;39:96-104
pubmed: 31099682
J Immunother Cancer. 2020 Apr;8(1):
pubmed: 32303614
J Clin Oncol. 2015 Oct 1;33(28):3177-85
pubmed: 26304878